SFRP2 and diabetic kidney disease: While DKD is associated with reduced bone density through mechanisms like Klotho deficiency, dysregulated Wnt and TGFβ signals [25–27], whether SFRP2-mediated Wnt inhibition represents novel renal-bone crosstalk remains unaddressed.